Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -0.34 is 26% above its 5-year average of -0.46, near the low end of its 5-year range (-1.18–6.00).
As of the fiscal period ended Tuesday, June 30, 2026. 38.65% above its 12-month average of -0.56.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -0.34.
DEBT TO EQUITY RATIO
-0.34
DEBT TO EQUITY RATIO AVG TTM
-0.56
DEBT TO EQUITY RATIO AVG 3Y
-0.62
DEBT TO EQUITY RATIO AVG 5Y
-0.46
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+38.65%
CURRENT VS 3Y AVG
+44.61%
CURRENT VS 5Y AVG
+25.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
-411.20%
vs the sector median at left
Tevogen Bio Holdings Inc.
Market Cap
$28.94M
Debt to Equity Ratio
-0.34
TTM Avg
-0.56
3Y Avg
-0.62
5Y Avg
-0.46
Market Cap
$29.27M
Debt to Equity Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$29.24M
Debt to Equity Ratio
0.10
TTM Avg
0.05
3Y Avg
0.16
5Y Avg
0.16
Market Cap
$29.37M
Debt to Equity Ratio
0.01
TTM Avg
2.29
3Y Avg
1.77
5Y Avg
1.50
Market Cap
$29.86M
Debt to Equity Ratio
0.01
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$27.94M
Debt to Equity Ratio
0.23
TTM Avg
0.18
3Y Avg
0.17
5Y Avg
0.13
Market Cap
$30.25M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.03
Market Cap
$27.21M
Debt to Equity Ratio
1.64
TTM Avg
4.27
3Y Avg
7.87
5Y Avg
4.84
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tevogen Bio Holdings Inc. (TVGN) | $28.94M | -0.34 | -0.56 | -0.62 | -0.46 |
| OneMedNet Corporation (ONMD)vs › | $29.27M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.24M | 0.10 | 0.05 | 0.16 | 0.16 |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | 0.01 | 2.29 | 1.77 | 1.50 |
| Context Therapeutics Inc. (CNTX)vs › | $29.86M | 0.01 | 0.00 | 0.00 | 0.00 |
| BeyondSpring Inc. (BYSI)vs › | $29.20M | N/A | 0.09 | 0.08 | 0.06 |
| aTyr Pharma, Inc. (ATYR)vs › | $27.94M | 0.23 | 0.18 | 0.17 | 0.13 |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.25M | 0.00 | 0.00 | 0.00 | 0.03 |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.21M | 1.64 | 4.27 | 7.87 | 4.84 |
| CervoMed Inc. (CRVO)vs › | $30.46M | 0.00 | 0.00 | 0.00 | 0.00 |
Debt/Equity
-0.34
Current Ratio
0.33
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -0.34 |
| 2026-03-31 | -0.31 |
| 2025-12-31 | -0.38 |
| 2025-09-30 | -0.96 |
| 2025-06-30 | -0.80 |
| 2025-03-31 | -0.62 |
| 2024-12-31 | -0.43 |
| 2024-09-30 | -0.48 |
| 2024-06-30 | -0.26 |
| 2024-03-31 | -0.36 |
| 2023-12-31 | -1.01 |
| 2023-09-30 | -1.03 |
| 2023-06-30 | -1.05 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | -1.18 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 0.00 |
| 2021-09-30 | 6.00 |
| 2021-06-30 | 0.00 |
